Filing Body
Page 1: UNITED STATES
Page 2: Item 1. Financial Statements.
Page 3: N/A
Page 4: N/A
Page 5: N/A
Page 6: N/A
Page 7: N/A
Page 8: N/A
Page 9: 2. Inventories
Page 10: 3. Derivative Instruments
Page 11: Foreign Exchange Contracts not Designated as Hedging Instruments
Page 12: Balance Sheet Classification
Page 13: N/A
Page 14: European Asset Optimization
Page 15: 6. Income Taxes
Page 16: 7. Debt
Page 17: 8. Contingencies
Page 18: N/A
Page 19: N/A
Page 20: Other Matters
Page 21: 9. Share Owners Equity
Page 22: N/A
Page 23: 10. Accumulated Other Comprehensive Loss
Page 24: 12. Earnings Per Share
Page 25: N/A
Page 26: 13. Supplemental Cash Flow Information
Page 27: N/A
Page 28: N/A
Page 29: N/A
Page 30: N/A
Page 31: N/A
Page 32: N/A
Page 33: N/A
Page 34: N/A
Page 35: Item 2. Management s Discussion and Analysis of Financial Condition and Results of Operations.
Page 36: Executive Overview Quarters ended June 30, 2013 and 2012
Page 37: Results of Operations Second Quarter of 2013 compared with Second Quarter of 2012
Page 38: Asia Pacific:
Page 39: North America:
Page 40: Executive Overview Six Months ended June 30, 2013 and 2012
Page 41: Europe:
Page 42: Europe:
Page 43: Interest Expense
Page 44: Discontinued Operations
Page 45: Cash Flows
Page 46: Investing activities:
Page 47: Forward Looking Statements
Page 48: Item 3. Quantitative and Qualitative Disclosure About Market Risk.
Page 49: Item 1. Legal Proceedings.
Page 50: Item 6. Exhibits.
Page 51: N/A
Page 52: INDEX TO EXHIBITS Exhibits
Exhibits
EX-12
EX-31.1
EX-31.2
EX-32.1
EX-32.2
EX-101.INS
EX-101.SCH
EX-101.CAL
EX-101.LAB
EX-101.PRE
EX-101.DEF
Interactive Data
XBRL Viewer